DOI: 10.4244/EIJV8I1A26

Brain malignancies and ionising radiation: more cases reported

Ariel Roguin1*, MD, PhD; Jacob Goldstein2, MD; Olivier Bar3, MD

Since our recent publication in EuroIntervention entitled “Brain tumours among interventional cardiologists: a cause for alarm? Report of four new cases from two cities and a review of the literature”1, we have received a lot of emails. This has been a thrilling, and at the same time a sad experience, as in each case, there has been a physician, a colleague of ours, a healer who treated patients in cathlabs around the world, and a family man who, in most cases, has died early due to the poor prognosis of this malignancy.

In our paper, we discussed four new cases: three GBM and one meningioma –all left-sided. We summarised the published data which comprised three interventional radiologists from Scandinavia and two interventional cardiologists from Toronto; overall there were nine cases1.

Recently, we were told that both patients from Canada had left-sided GBM (at the time we wrote the paper we did not have this information), thus making it 6 out of 6 with left-side involvement.

In the past weeks we were able to collect data on additional patients:

Left GBM

1. 53-year-old male, a paediatric electrophysiologist from Zürich, Switzerland, with 20 years of cathlab work.

2 67-year-old male physician from Virginia, USA, who implanted pacemakers for more than 29 years.

3. 59-year-old male interventional cardiologist from Dundee, Scotland, with 29 years of experience in the cathlab.

4. 34-year-old male interventional cardiologist from Florida, USA.

GBM data – side not yet known

5. 54-year-old male interventional cardiologist from Kentucky, USA.

6. 65-year-old male interventional cardiologist from Illinois, USA, with midline GBM.

7. 52-year-old female interventional radiologist from the West of Scotland, UK.

8. 55-year-old male interventional radiologist from the West of Scotland, UK.

Left parotids

1. 62-year-old male interventional cardiologist from London, UK, with 27 years of experience in the cathlab.

In summary, to-date we have collected, using primitive communication methods:

Twelve cases of GBM as well as five brain tumours [not GBM] and one parotid. Overall, as of March 3, 2012 –18 cases.

Of the 13 malignant brain tumours, we still don’t know the side involved in three of the cases. In ten of the cases we know the side involved –in nine of these cases– it was the left side!

The parotids as well as the meningioma are left-sided.

So, when the information exists, in 11 out of 12, 92% of cases, the side involved is the left side.

We have received information in three additional reports of GBM in cardiologists , but these individuals were not exposed to radiation in the cathlab. We did not evaluate for thyroid or haematological malignancies, but rather remained focused on brain and head tumours.

Solid evidence-based medicine in this field is lacking, and the cases reported in the original paper and the additional ones mentioned above could all be a simple matter of chance without any relationship to occupational exposure. More data is needed prior to establishing a causal relationship. No one can implicate radiation exposure to the aetiology of a neoplasm based on the identification of a few patients affected. Still, it is reasonable to assume that ionising radiation does not improve health!

We do not think we should jump to conclusions, but it is certainly an issue worth looking into.

Our community should discuss a more comprehensive methodology to collect “hard” evidence. Among the options are: 1) to send out requests by notification in journals in an endeavour to collect cases by self-reporting (anonymous of course for personal protection); 2) to use the national societies of interventional cardiology; 3) to send letters to cathlab directors to report cancers in their colleagues, living or dead, again without personal identifiers but with age, years of interventional work and type of cancer, and if fatal; 4) to send the information to interventional radiologists.

We have to verify the magnitude of this finding and to hope that this is the whole iceberg and not just the tip of the iceberg.

Reference

Volume 8 Number 1
May 15, 2012
Volume 8 Number 1
View full issue


Key metrics

On the same subject

Snapshot

May 20, 2024
Continue learning with EuroIntervention!
free

Editorial

10.4244/EIJ-E-24-00027 May 20, 2024
Can DAPT be discontinued at one month after PCI in high bleeding risk patients presenting with ACS?
Hong M and Lee Y
free

Editorial

10.4244/EIJ-E-24-00015 May 20, 2024
When can we discharge patients after chronic total occlusion percutaneous coronary intervention?
Lombardi W and Azzalini L
free

Editorial

10.4244/EIJ-E-24-00017 May 20, 2024
Is this the end of the ultrathin-strut hypothesis?
Bangalore S and Finn A
free

Original Research

10.4244/EIJ-D-23-00605 May 20, 2024
Impact of coronary calcium morphology on intravascular lithotripsy
McInerney A et al

Original Research

10.4244/EIJ-D-23-00563 May 20, 2024
Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects
Ikegami R et al

Debate

10.4244/EIJ-E-24-00014 May 20, 2024
Atherectomy for calcified plaques: orbital for most? Pros and cons
Kirtane A and Ribichini F
free
Trending articles
339.33

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
315.18

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
295.45

Expert consensus

10.4244/EIJ-D-21-00898 Sep 20, 2022
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Secemsky E et al
free
74.6

Clinical research

10.4244/EIJ-D-22-01062 Aug 21, 2023
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation
Doldi PM et al
53.75

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
42.95

Clinical research

10.4244/EIJ-D-23-00282 Jul 17, 2023
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
Kodali SK et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved